Beate Schmöele-Thoma (Beate Schmoele-Thoma, Beate Schmöle-Thoma)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 7

Top Topics

Extracorporeal Membrane Oxygenation

Top Venues

Human vaccines & immunotherapeutics

Expert review of vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Verstraeten, Mark A Fletcher, Jose A Suaya, Sally Jackson, Cassandra K Hall-Murray, Daniel A Scott, Beate Schmöele-Thoma, Raul E Isturiz, Bradford D Gessner
Diabetes mellitus as a vaccine-effect modifier: a review. Expert review of vaccines 19 (5) (2020)
Erica Chilson, Daniel A Scott, Beate Schmöele-Thoma, Wendy Watson, Mary M Moran, Raul Isturiz
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence. Human vaccines & immunotherapeutics 16 (11) (2020)
Beate Schmöele-Thoma, Martin van Cleeff, Richard N Greenberg, Alejandra Gurtman, Thomas R Jones, Vani Sundaraiyer, William C Gruber, Daniel A Scott
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults. Human vaccines & immunotherapeutics 15 (3) (2019)
Christine Juergens, James Trammel, Yasuko Shoji, Scott Patterson, Wendy Watson, Chris Webber, William C Gruber, Daniel A Scott, Beate Schmöele-Thoma
Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations. Human vaccines & immunotherapeutics 14 (8) (2018)
Bhagirath B Solanki, Christine Juergens, Manojkumar B Chopada, Pravin Supe, Vani Sundaraiyer, Natacha Le Dren-Narayanin, Mark W Cutler, William C Gruber, Daniel A Scott, Beate Schmöele-Thoma
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial. Human vaccines & immunotherapeutics 13 (9) (2018)
Allison R Thompson, Nicola P Klein, H Jackson Downey, Scott Patterson, Vani Sundaraiyer, Wendy Watson, Keri Clarke, Kathrin U Jansen, Shite Sebastian, William C Gruber, Daniel A Scott, Beate Schmöele-Thoma
Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial. Human vaccines & immunotherapeutics 15 (2) (2018)
Raul E Isturiz, Cassandra Hall-Murray, John M McLaughlin, Vincenza Snow, Beate Schmöele-Thoma, Chris Webber, Allison Thompson, Daniel A Scott
Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age. Expert review of vaccines 17 (1) (2017)